DBV Technologies S.A. (DBVTF)
OTCMKTS · Delayed Price · Currency is USD
4.800
+0.900 (23.08%)
At close: Jan 27, 2026
DBV Technologies Market Cap
DBV Technologies has a market cap or net worth of $1.31 billion as of February 12, 2026. Its market cap has increased by 1,491.62% in one year.
Market Cap
1.31B
Enterprise Value
1.24B
Revenue
5.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.80
Market Cap Chart
Since March 29, 2012, DBV Technologies's market cap has increased from 105.11M to 1.31B, an increase of 1,141.56%. That is a compound annual growth rate of 19.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.31B | 63.92% |
| Dec 31, 2025 | 796.16M | 1,090.30% |
| Dec 31, 2024 | 66.89M | -66.00% |
| Dec 29, 2023 | 196.73M | -37.73% |
| Dec 30, 2022 | 315.93M | 65.17% |
| Dec 31, 2021 | 191.28M | -34.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 413.38M |
| CytoDyn | 304.50M |
| Silence Therapeutics | 213.03M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |